Phacilitate Talks podcast Episode 7 Nina Bauer, MilliporeSigma and Lance Holland, bluebird bio

Episode 7 Nina Bauer, MilliporeSigma and Lance Holland, bluebird bio

Nina and Lance share their views on remotely managing CDMOs and recruiting and retaining diverse talent


 
In this episode, Anthony and Michael talk to Nina Bauer, the Head of Commercial, Gene Editing and Novel Modalities at MilliporeSigma and Lance Holland, Associate Director, External Vector Manufacturing at bluebird bio.

The discussion starts with a look at the challenges brought by Covid-19 with regards to finding a new way of working with your CDMO, in particular conducting audits. Anthony's solution? Use GoPros!

Nina puts a question to the group around recruiting diverse talent. With a major talent gap across our industry, this surely has to have many benefits?

The conversation flowed so well that we ran out of time, keep your eye out for part II of this conversation coming soon...

Enjoy and, as always, please share your feedback. 

DISCLAIMER: opinions expressed are solely the interviewee’s own and do not express the views or opinions of their respective employers

You can also subscribe to the audio-only version, wherever you get your podcasts: 
Phacilitate Talks on Apple Podcasts
Phacilitate Talks on Spotify
Phacilitate Talks on Stitcher